Nexmectin 18.7 mg/g Oral Paste for Horses

País: Irlanda

Idioma: anglès

Font: HPRA (Health Products Regulatory Authority)

ingredients actius:

Ivermectin

Disponible des:

ECO Animal Health Europe Limited

Codi ATC:

QP54AA01

Designació comuna internacional (DCI):

Ivermectin

Dosis:

18.7 milligram(s)/gram

formulario farmacéutico:

Oral paste

tipo de receta:

POM: Prescription Only Medicine as defined in relevant national legislation

Área terapéutica:

ivermectin

Estat d'Autorització:

Authorised

Data d'autorització:

2019-06-21

Fitxa tècnica

Health Products Regulatory Authority
04 July 2019
CRN000YL4
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Nexmectin 18.7 mg/g Oral Paste for Horses
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains:
ACTIVE SUBSTANCE:
Ivermectin 18.7 mg
EXCIPIENT(S):
Titanium dioxide (E171) 20 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Oral Paste
A white homogeneous paste
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of nematode or arthropod infection due to:
Large strongyles:
_Strongylus vulgaris_ (adults and L
4
stage larvae [arterial])
_Strongylus edentatus_ (adults and L
4
stage larvae [tissue])
_Strongylus equinus_ (adults)
Small strongyles (including benzimidazole resistant strains):
_Cyathostomum _spp.(adults and luminal L
4
stage larvae)
_Cylicocyclus _spp. (adults and luminal L
4
stage larvae)
_Cylicodontophorus _spp. (adults and luminal L
4
stage larvae)
_Cylicostephanus _spp. (adults and luminal L
4
stage larvae)
_Gyalocephalus _spp. (adults and luminal L
4
stage larvae)
Ascarids:
_Parascaris equorum_ (luminal L
5
larvae and adults)
Pinworms:
_Oxyuris equi_ (L
4
stage larvae and adults)
Neck threadworms:
_Onchocerca_ spp. (microfilariae)
Stomach bots:
_Gasterophilus _spp_._ (oral and gastric stages)
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
Health Products Regulatory Authority
04 July 2019
CRN000YL4
Page 2 of 5
Do not use in dogs or cats as severe adverse reactions may occur.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Some horses with heavy infections of _Onchocerca_ spp. microfilariae
have experienced oedema and pruritus following treatment,
such reactions are assumed to be the result of death of large numbers
of microfilariae. These signs resolve within a few days
but symptomatic treatment may be advisable.
Care should be taken to avoid the following practices because they
increase the risk of